Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer

Completed · Phase 1/Phase 2

Conditions studied: Non Small Cell Lung Cancer, Lung Cancer, Stage IIIA Non Small Cell Lung Cancer, Stage IIIB Non Small Cell Lung Cancer

In brief

A study to measure the safety and effectiveness of S-3304 when given in combination with conventional chemo-radiation therapy in patients with locally advanced non-small cell lung cancer.

Key facts

Study ID

NCT00078390

Run by

Shionogi

People needed

9

Starts

2003-02-01

Expected to finish

2006-10-26

Last updated by the study team

2018-05-02

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• newly diagnosed non-small cell lung cancer of stage IIIA non-resectable or of stage IIIB without pleural effusion
• ECOG performance status 0-1
• adequate organ function
• clinically indicated and able to receive conventional chemoradiation therapy

You may not qualify if…

• patients with prior history of cancer, other than basal cell carcinoma after appropriate treatment, or prior systemic chemotherapy treatment
• patients with other serious intercurrent illness including HIV/AIDS, or contraindicated for paclitaxel/carboplatin or thoracic irradiation treatment

Where it is running

• Scripps Cancer Institute — La Jolla, California, United States
• Lombardi Cancer Center — Washington D.C., District of Columbia, United States
• University of Kansas Cancer Center — Kansas City, Kansas, United States
• VA Medical Center-East Orange (study available to veterans only) — East Orange, New Jersey, United States
• The Cleveland Clinic — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.